UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Metabolic plasticity in CLL: adaptation to the hypoxic niche

Leukemia, 2016-01, Vol.30 (1), p.65-73

2016

Volltextzugriff (PDF)

Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors

Leukemia, 2005-10, Vol.19 (10), p.1751-1759

2005

Volltextzugriff (PDF)

The in Vitro Effects of Triiodothyronine on Epidermal Growth Factor-Induced Trophoblast Function

The journal of clinical endocrinology and metabolism, 2005-03, Vol.90 (3), p.1655-1661

2005

Volltextzugriff (PDF)

PTTG’s C-terminal PXXP motifs modulate critical cellular processes in vitro

Journal of molecular endocrinology, 2004-12, Vol.33 (3), p.663-677

2004

Volltextzugriff (PDF)

Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain production

Blood cancer journal (New York), 2011-10, Vol.1 (10), p.e39-e39

2011

Volltextzugriff (PDF)

Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15dΔ12,14,PGj2

Leukemia, 2009-02, Vol.23 (2), p.292-304

2009

Volltextzugriff (PDF)

Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15dΔ PGJ

Leukemia, 2009-02, Vol.23 (2), p.292-304

2009

Volltextzugriff (PDF)

Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15d Delta super(12,14),PGJ sub(2)

Leukemia, 2009-02, Vol.23 (2), p.292-304

2009

Volltextzugriff (PDF)

Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15d[Delta]12,14,PGJ2

Leukemia, 2009-02, Vol.23 (2), p.292

2009

Volltextzugriff (PDF)

The Histone Deacetylase Inhibitor Sodium Valproate Has In Vitro Anti-Neoplastic Activity Against Primary Multiple Myeloma Cells and Cell Lines Both Alone and in Combination with Velcade

Blood, 2005-11, Vol.106 (11), p.5148-5148

2005

Volltextzugriff (PDF)

Altered SMRT levels disrupt vitamin D sub(3) receptor signalling in prostate cancer cells

Oncogene, 2004-09, Vol.23 (40), p.6712-6725

2004

Volltextzugriff (PDF)

Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15dDelta12,14,PGJ2

Leukemia, 2009-02, Vol.23 (2), p.292

2009

Volltextzugriff (PDF)

The aldo-keto reductase AKR1C3 contributes to 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol mediated oxidative DNA damage in myeloid cells: Implications for leukemogenesis

Mutation research, 2009-03, Vol.662 (1), p.67-74

2009

Volltextzugriff (PDF)

Epigenetic repression of transcription by the Vitamin D 3 receptor in prostate cancer cells

The Journal of steroid biochemistry and molecular biology, 2004-05, Vol.89, p.251-256

2004

Volltextzugriff (PDF)

A framework for tracer-based metabolism in mammalian cells by NMR

Scientific reports, 2019-02, Vol.9 (1), p.2520, Article 2520

2019

Volltextzugriff (PDF)

PEP005, a selective small-molecule activator of protein kinase C, has potent antileukemic activity mediated via the delta isoform of PKC

Blood, 2005-08, Vol.106 (4), p.1362-1368

2005

Volltextzugriff (PDF)

Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate

British journal of cancer, 2014-03, Vol.110 (6), p.1506-1516

2014

Volltextzugriff (PDF)

Combined bezafibrate and medroxyprogesterone acetate have efficacy without haematological toxicity in elderly and relapsed acute myeloid leukaemia (AML)

British journal of haematology, 2010-04, Vol.149 (1), p.65-69

2010

Volltextzugriff (PDF)

Analysis of Epstein-Barr Virus Gene Polymorphisms in Normal Donors and in Virus-Associated Tumors From Different Geographic Locations

Blood, 1996-11, Vol.88 (9), p.3491-3501

1996

Volltextzugriff (PDF)

HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2

Journal of Virology, 1993-12, Vol.67 (12), p.7428-7435

1993

Volltextzugriff (PDF)

A Synthetic Azinomycin Analogue with Demonstrated DNA Cross-Linking Activity: Insights into the Mechanism of Action of this Class of Antitumor Agent

Angewandte Chemie (International ed.), 2000-10, Vol.39 (19), p.3467-3470

2000

Volltextzugriff (PDF)

Repression at a distance by the global regulator KorB of promiscuous IncP plasmids

Molecular microbiology, 1999-05, Vol.32 (3), p.519-532

1999

Volltextzugriff (PDF)

Synthesis, cytotoxicity and DNA cross-linking activity of symmetrical dimers based upon the epoxide domain of the azinomycins

Chemical communications (Cambridge, England), 2000-01 (23), p.2325-2326

2000

Volltextzugriff (PDF)

BHRF1, a viral homologue of the Bcl-2 oncogene, is conserved at both the sequence and functional level in different Epstein-Barr virus isolates

Journal of general virology, 1997-11, Vol.78 (11), p.2987-2999

1997

Volltextzugriff (PDF)

Characterisation of Histone Deacetylase (HDAC) Expression Profiles in Acute Myeloid Leukaemia: A Basis for the Development of Targeted Therapy Using Histone Deacetylase Inhibitors

Blood, 2004-11, Vol.104 (11), p.1123-1123

2004

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)
Japanisch
(6)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Metabolic plasticity in CLL: adaptation to the hypoxic niche

Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors

The in Vitro Effects of Triiodothyronine on Epidermal Growth Factor-Induced Trophoblast Function

PTTG’s C-terminal PXXP motifs modulate critical cellular processes in vitro

Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain production

Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15dΔ12,14,PGj2

Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15dΔ PGJ

Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15d Delta super(12,14),PGJ sub(2)

Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15d[Delta]12,14,PGJ2

The Histone Deacetylase Inhibitor Sodium Valproate Has In Vitro Anti-Neoplastic Activity Against Primary Multiple Myeloma Cells and Cell Lines Both Alone and in Combination with Velcade

Altered SMRT levels disrupt vitamin D sub(3) receptor signalling in prostate cancer cells

Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15dDelta12,14,PGJ2

The aldo-keto reductase AKR1C3 contributes to 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol mediated oxidative DNA damage in myeloid cells: Implications for leukemogenesis

Epigenetic repression of transcription by the Vitamin D 3 receptor in prostate cancer cells

A framework for tracer-based metabolism in mammalian cells by NMR

PEP005, a selective small-molecule activator of protein kinase C, has potent antileukemic activity mediated via the delta isoform of PKC

Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate

Combined bezafibrate and medroxyprogesterone acetate have efficacy without haematological toxicity in elderly and relapsed acute myeloid leukaemia (AML)

Analysis of Epstein-Barr Virus Gene Polymorphisms in Normal Donors and in Virus-Associated Tumors From Different Geographic Locations

HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2

A Synthetic Azinomycin Analogue with Demonstrated DNA Cross-Linking Activity: Insights into the Mechanism of Action of this Class of Antitumor Agent

Repression at a distance by the global regulator KorB of promiscuous IncP plasmids

Synthesis, cytotoxicity and DNA cross-linking activity of symmetrical dimers based upon the epoxide domain of the azinomycins

BHRF1, a viral homologue of the Bcl-2 oncogene, is conserved at both the sequence and functional level in different Epstein-Barr virus isolates

Characterisation of Histone Deacetylase (HDAC) Expression Profiles in Acute Myeloid Leukaemia: A Basis for the Development of Targeted Therapy Using Histone Deacetylase Inhibitors

Suchergebnisse filtern